$0.56Day Range$0.59
Key Statistics
Market Cap
$6.02M
Shares Outstanding
10.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 29, 2024
Round Lot
100
Locale
US
Trading Data
Day Open
$0.58
Day High
$0.59
Day Low
$0.56
Volume
76.6K
VWAP
$0.57
Prev Close
$0.58
Transactions
--
Acc. Volume
--
About Gelteq Limited Ordinary Shares
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
Identifiers
- CIK
- 0001920092
- Ticker Root
- GELS
About Gelteq Limited Ordinary Shares (GELS) Stock
Gelteq Limited Ordinary Shares (GELS) closed the 2026-09-18 session at $0.56, down 3.07% versus the previous close (-0.02). The stock opened at $0.58 and traded between $0.56 and $0.59 during that session. Session trading volume was 77K shares. The volume-weighted average price (VWAP) is $0.57.
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
Gelteq Limited Ordinary Shares has a market capitalization of $6.0 million. GELS is listed on the XNAS exchange. The company employs approximately 8 people. The recorded listing date is 2024-10-29.
On this page you can find market GELS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.